TABLE 1

Clinical characteristics of the subjects

Swedish cohort
Finnish cohort
Type 1 diabetesLADAType 2 diabetesControlLADAType 2 diabetesControl
n (M/F)394/32473/91553/447553/44783/113361/315338/366
GADA positive (%)4610001000
Insulin treatment (%)995816047420
Age at onset/visit (years)17.9 ± 9.252.4 ± 11.454.3 ± 8.870.1 ± 2.954.6 ± 11.454.8 ± 9.353.7 ± 11.4
BMI (kg/m2)23.8 ± 3.325.9 ± 5.629.2 ± 4.827.6 ± 4.426.8 ± 5.029.1 ± 4.825.9 ± 3.7
Fasting plasma glucose (mmol/l)12.4 ± 5.311.8 ± 4.611.0 ± 3.55.3 ± 0.410.3 ± 4.39.0 ± 3.05.3 ± 0.5
Fasting C-peptide (nmol/l)0.04 ± 0.120.40 ± 0.451.04 ± 0.520.43 ± 0.400.66 ± 0.370.41 ± 0.22
  • Data are means ± SD.